Buccal Drug Delivery Systems Market by Type (Buccal Tablets, Oral Sprays, Sublingual Films), Application (Angina Pectoris, Pain Management, Smoking Cessation), End-user - Global Forecast 2024-2030

Buccal Drug Delivery Systems Market by Type (Buccal Tablets, Oral Sprays, Sublingual Films), Application (Angina Pectoris, Pain Management, Smoking Cessation), End-user - Global Forecast 2024-2030


The Buccal Drug Delivery Systems Market size was estimated at USD 2.23 billion in 2023 and expected to reach USD 2.43 billion in 2024, at a CAGR 9.34% to reach USD 4.18 billion by 2030.

Global Buccal Drug Delivery Systems Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Buccal Drug Delivery Systems Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Buccal Drug Delivery Systems Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Buccal Drug Delivery Systems Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Amgen Inc., Aquestive Therapeutics, Inc., ARx, LLC, AstraZeneca Plc, Camurus, Catalent, Inc., Cure Pharmaceutical, DuPont de Nemours, Inc., Generex Biotechnology, Herantis Pharma PLC, Indivior PLC, LTS Lohmann Therapie-Systeme AG, MedLab Clinical Ltd, Nektar Therapeutics, Novartis AG, Novo Nordisk A/S, Pfizer Inc., Sorrento Therapeutics, Inc., Tesa Labtec GmbH, and Vectura Group.

Market Segmentation & Coverage



This research report categorizes the Buccal Drug Delivery Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
Buccal Tablets
Oral Sprays
Sublingual Films
Application
Angina Pectoris
Pain Management
Smoking Cessation
End-user
Ambulatory Centers
Hospitals
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Buccal Drug Delivery Systems Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Buccal Drug Delivery Systems Market?
3. What are the technology trends and regulatory frameworks in the Buccal Drug Delivery Systems Market?
4. What is the market share of the leading vendors in the Buccal Drug Delivery Systems Market?
5. Which modes and strategic moves are suitable for entering the Buccal Drug Delivery Systems Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Buccal Drug Delivery Systems Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High preferences due to ease of drug administration and termination
5.1.1.2. Prevalence of chronic diseases coupled with growth in geriatric population
5.1.1.3. Increased demand for drug development globally
5.1.2. Restraints
5.1.2.1. Difficulty in administration of large doses
5.1.3. Opportunities
5.1.3.1. Advances in nanoparticulate drug delivery approaches for buccal administration
5.1.3.2. Developments in buccal mucoadhesive tablets
5.1.4. Challenges
5.1.4.1. Issues with patient acceptability for non ubiquitous drug distribution within saliva
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Buccal Drug Delivery Systems Market, by Type
6.1. Introduction
6.2. Buccal Tablets
6.3. Oral Sprays
6.4. Sublingual Films
7. Buccal Drug Delivery Systems Market, by Application
7.1. Introduction
7.2. Angina Pectoris
7.3. Pain Management
7.4. Smoking Cessation
8. Buccal Drug Delivery Systems Market, by End-user
8.1. Introduction
8.2. Ambulatory Centers
8.3. Hospitals
9. Americas Buccal Drug Delivery Systems Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Buccal Drug Delivery Systems Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Buccal Drug Delivery Systems Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. 3M Company
13.1.2. Amgen Inc.
13.1.3. Aquestive Therapeutics, Inc.
13.1.4. ARx, LLC
13.1.5. AstraZeneca Plc
13.1.6. Camurus
13.1.7. Catalent, Inc.
13.1.8. Cure Pharmaceutical
13.1.9. DuPont de Nemours, Inc.
13.1.10. Generex Biotechnology
13.1.11. Herantis Pharma PLC
13.1.12. Indivior PLC
13.1.13. LTS Lohmann Therapie-Systeme AG
13.1.14. MedLab Clinical Ltd
13.1.15. Nektar Therapeutics
13.1.16. Novartis AG
13.1.17. Novo Nordisk A/S
13.1.18. Pfizer Inc.
13.1.19. Sorrento Therapeutics, Inc.
13.1.20. Tesa Labtec GmbH
13.1.21. Vectura Group
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. BUCCAL DRUG DELIVERY SYSTEMS MARKET RESEARCH PROCESS
FIGURE 2. BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2023 VS 2030
FIGURE 3. BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BUCCAL DRUG DELIVERY SYSTEMS MARKET DYNAMICS
FIGURE 7. BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. BUCCAL DRUG DELIVERY SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. BUCCAL DRUG DELIVERY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings